Poorly differentiated adenocarcinoma of the colon: subsite location and clinicopathologic features

International Journal of Colorectal Disease

Volumn 30, Issue 2, 2015, Pages 187-196

  Imai, Yasuo ^a  

^a FUJI HEAVY INDUSTRIES LTD   (Japan)

Author keywords

Clinicopathologic features; Colon; Microsatellite instability; Poorly differentiated adenocarcinoma; Subsite

Indexed keywords

CYTOKERATIN 20; MUCIN 5AC;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PROGNOSIS; CLINICAL FEATURE; COLON ADENOCARCINOMA; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FOLLOW UP; GENE EXPRESSION; HEREDITY; HUMAN; IMMUNOHISTOCHEMISTRY; INVESTIGATIVE PROCEDURES; JAPAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MICROSATELLITE STABILITY; OVERALL SURVIVAL; POORLY DIFFERENTIATED ADENOCARCINOMA; PRIORITY JOURNAL; CELL DIFFERENTIATION; COLON TUMOR; GENETICS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SURVIVAL; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84922102649     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-014-2070-0     Document Type: Article

References (45)

1. Iacopetta B (2002) Are there two sides to colorectal cancer? Int J Cancer 101:403–408
2. Bufill JA (1990) Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 113:779–788
3. Gervaz P, Bucher P, Morel P (2004) Two colons-two cancers: paradigm shift and clinical implications. J Surg Oncol 88:261–266
4. Weiss JM, Pfau PR, O'Connor ES, King J, LoConte N, Kennedy G, Smith MA (2011) Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results—Medicare data. J Clin Oncol 29:4401–4409. doi:10.1200/JCO.2011.36.4414
5. Wray CM, Ziogas A, Hinojosa MW, Le H, Stamos MJ, Zell JA (2009) Tumor subsite location within the colon is prognostic for survival after colon cancer diagnosis. Dis Colon Rectum 52:1359–1366. doi:10.1007/DCR.0b013e3181a7b7de
6. Lengauer C, Kinzler KW, Vogelstein B (1997) Genetic instability in colorectal cancers. Nature 386:623–627
7. Haydon AM, Jass JR (2002) Emerging pathways in colorectal-cancer development. Lancet Oncol 3:83–88
8. Kim H, Jen J, Vogelstein B, Hamilton SR (1994) Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 145:148–156
9. Jass JR, Do KA, Simms LA, Iino H, Wynter C, Pillay SP, Searle J, Radford-Smith G, Young J, Leggett B (1998) Morphology of sporadic colorectal cancer with DNA replication errors. Gut 42:673–679
10. Guastadisegni C, Colafranceschi M, Ottini L, Dogliotti E (2010) Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data. Eur J Cancer 46:2788–2798. doi:10.1016/j.ejca.2010.05.009
11. Boland CR, Goel A (2010) Microsatellite instability in colorectal cancer. Gastroenterology 138:2073–2087. doi:10.1053/j.gastro.2009.12.064
12. Hamilton SR, Bosman FT, Boffetta P, Ilyas M, Morreau H, Nakamura SI, Quirke P, Riboli E, Sobin LH (2013) Carcinoma of the colon and rectum. In: Bozman FT, Carneiro F, Hruban RH, Theise ND (eds) WHO classification of tumours of the digestive system, 4th edn. IARC Press, Lyon, pp 134–146
13. American Joint Committee on Cancer (2009) Colon and rectum cancer staging, 7th edn. http://www.cancerstaging.org/staging/index.html. Accessed 18 October 2012
14. Imai Y, Yamagishi H, Fukuda K, Okamura T, Ono Y, Ban S, Inoue T, Ueda Y (2014) Expression of cytokeratin 20 indicates invasive histological phenotype in poorly differentiated colorectal adenocarcinoma. Anticancer Res 34:159–168
15. The Japanese Society for Cancer of the Colon and Rectum (2013) The general rules of Japanese classification of colorectal carcinoma, 8th edn. Kanehara, Tokyo
16. Marcus VA, Madlensky L, Gryfe R, Kim H, So K, Millar A, Temple LK, Hsieh E, Hiruki T, Narod S, Bapat BV, Gallinger S, Redston M (1999) Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 23:1248–1255
17. Yamagishi H, Imai Y, Okamura T, Fukuda K, Ono Y, Ban S, Inoue T, Ueda Y (2013) Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma. J Gastroenterol Hepatol 28:1815–1822. doi:10.1111/jgh.12319
18. Kemp CJ, Wheldon T, Balmain A (1994) p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nat Genet 8:66–69
19. Smith ML, Fornace AJ Jr (1995) Genomic instability and the role of p53 mutations in cancer cells. Curr Opin Oncol 7:69–75
20. Starzynska T, Bromley M, Ghosh A, Stern PL (1992) Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer 66:558–562
21. Goh HS, Yao J, Smith DR (1995) p53 point mutation and survival in colorectal cancer patients. Cancer Res 55:5217–5221
22. Ishihara S, Watanabe T, Akahane T, Shimada R, Horiuchi A, Shibuya H, Hayama T, Yamada H, Nozawa K, Matsuda K, Maeda K, Sugihara K (2012) Tumor location is a prognostic factor in poorly differentiated adenocarcinoma, mucinous adenocarcinoma, and signet-ring cell carcinoma of the colon. Int J Colorectal Dis 27:371–379. doi:10.1007/s00384-011-1343-0
23. Sinicrope FA, Rego RL, Foster N, Sargent DJ, Windschitl HE, Burgart LJ, Witzig TE, Thibodeau SN (2006) Microsatellite instability accounts for tumor site-related differences in clinicopathologic variables and prognosis in human colon cancers. Am J Gastroenterol 101:2818–2825
24. Kim YH, Min BH, Kim SJ, Choi HK, Kim KM, Chun HK, Lee H, Kim JY, Chang DK, Son HJ, Rhee PL, Rhee JC, Kim JJ (2010) Difference between proximal and distal microsatellite-unstable sporadic colorectal cancers: analysis of clinicopathological and molecular features and prognoses. Ann Surg Oncol 17:1435–1441. doi:10.1245/s10434-009-0888-4
25. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855–4878
26. Iacopetta B (2003) TP53 mutation in colorectal cancer. Hum Mutat 21:271–276
27. Thompson SL, Bakhoum SF, Compton DA (2010) Mechanisms of chromosomal instability. Curr Biol 20:R285–R295. doi:10.1016/j.cub.2010.01.034
28. McGregor DK, Wu TT, Rashid A, Luthra R, Hamilton SR (2004) Reduced expression of cytokeratin 20 in colorectal carcinomas with high levels of microsatellite instability. Am J Surg Pathol 28:712–718
29. Biemer-Hüttmann AE, Walsh MD, McGuckin MA, Simms LA, Young J, Leggett BA, Jass JR (2000) Mucin core protein expression in colorectal cancers with high levels of microsatellite instability indicates a novel pathway of morphogenesis. Clin Cancer Res 6:1909–1916
30. Losi L, Scarselli A, Benatti P, Ponz de Leon M, Roncucci L, Pedroni M, Borghi F, Lamberti I, Rossi G, Marino M, Ponti G, Zangardi G, Menigatti M, Di Gregorio C (2004) Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas. Pathol Res Pract 200:371–377
31. Imai Y, Yamagishi H, Fukuda K, Ono Y, Inoue T, Ueda Y (2013) Differential mucin phenotypes and their significance in a variation of colorectal carcinoma. World J Gastroenterol 19:3957–3968. doi:10.3748/wjg.v19.i25.3957
32. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363:558–561
33. Cottu PH, Muzeau F, Estreicher A, Fléjou JF, Iggo R, Thomas G, Hamelin R (1996) Inverse correlation between RER+ status and p53 mutation in colorectal cancer cell lines. Oncogene 13:2727–2730
34. Gendler SJ, Spicer AP (1995) Epithelial mucin genes. Annu Rev Physiol 57:607–634
35. Hanski C, Riede E, Gratchev A, Foss HD, Böhm C, Klussmann E, Hummel M, Mann B, Buhr HJ, Stein H, Kim YS, Gum J, Riecken EO (1997) MUC2 gene suppression in human colorectal carcinomas and their metastases: in vitro evidence of the modulatory role of DNA methylation. Lab Invest 77:685–695
36. Ookawa K, Kudo T, Aizawa S, Saito H, Tsuchida S (2002) Transcriptional activation of the MUC2 gene by p53. J Biol Chem 277:48270–48275
37. Blank M, Klussmann E, Krüger-Krasagakes S, Schmitt-Gräff A, Stolte M, Bornhoeft G, Stein H, Xing PX, McKenzie IF, Verstijnen CP, Riecken EO, Hanski C (1994) Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types. Int J Cancer 59:301–306
38. Mizoshita T, Tsukamoto T, Inada KI, Hirano N, Tajika M, Nakamura T, Ban H, Tatematsu M (2007) Loss of MUC2 expression correlates with progression along the adenoma-carcinoma sequence pathway as well as de novo carcinogenesis in the colon. Histol Histopathol 22:251–260
39. Hirano K, Nimura S, Mizoguchi M, Hamada Y, Yamashita Y, Iwasaki H (2012) Early colorectal carcinomas: CD10 expression, mucin phenotype and submucosal invasion. Pathol Int 62:600–611. doi:10.1111/j.1440-1827.2012.02850.x
40. Bartman AE, Sanderson SJ, Ewing SL, Niehans GA, Wiehr CL, Evans MK, Ho SB (1999) Aberrant expression of MUC5AC and MUC6 gastric mucin genes in colorectal polyps. Int J Cancer 80:210–218
41. Buisine MP, Janin A, Maunoury V, Audié JP, Delescaut MP, Copin MC, Colombel JF, Degand P, Aubert JP, Porchet N (1996) Aberrant expression of a human mucin gene (MUC5AC) in rectosigmoid villous adenoma. Gastroenterology 110:84–91
42. Bara J, Loisillier F, Burtin P (1980) Antigens of gastric and intestinal mucous cells in human colonic tumors. Br J Cancer 41:209–221
43. Bara J, Languille O, Gendron MC, Daher N, Martin E, Burtin P (1983) Immunohistological study of precancerous mucus modification in human distal colonic polyps. Cancer Res 43:3885–3891
44. Biemer-Hüttmann AE, Walsh MD, McGuckin MA, Ajioka Y, Watanabe H, Leggett BA, Jass JR (1999) Immunohistochemical staining patterns of MUC1, MUC2, MUC4, and MUC5AC mucins in hyperplastic polyps, serrated adenomas, and traditional adenomas of the colorectum. J Histochem Cytochem 47:1039–1048
45. Kim JH, Rhee YY, Bae JM, Cho NY, Kang GH (2013) Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer. Am J Surg Pathol 37:1532–1541. doi:10.1097/PAS.0b013e31829ab1c1